Gilead Sciences, Inc.

GILD - Valuation bargain, but technically awful. Future BUY

129
GILD has been a great investment and I believe it will continue to be a good company to own long term. The valuation using multiple methods is outstanding compared to it's peers. Fundamentally, the question has been regarding future growth. GILD will have to find new ways to generate future sales growth to replace the expected slower growth from it's hep C blockbusters. Investors are concern GILD could be a value trap. Even with the questions about future growth, this stock seems crazy low compared to it's peers.

From a trader's perspective. Price action is awful and it may stay bearish for awhile. I don't see a favorable long swing trade entry at this time, but this sell off will get over done.

I plan on also evaluating my "investment options". One possible option to consider is a buy-write around $80 - 78. Options are currently selling at discount, so ideally I would like to IV go up to sell them a a premium.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。